The Cincinnati Enquirer ran an article about a new a state-created venture fund charged with raising $100 million and steering at least half of it into Ohio startup companies. The new company, Buckeye Venture Partners, will be headed by a unit of Western & Southern Financial Group of Cincinnati.  Buckeye Venture Partners will serve as […]

The San Francisco Chronicle reported that venture capital funding rose for the first time in four years in 2004.  Venture investments totaled $20.41 billion last year, up 8 percent from 2003.  While the total number of financing rounds fell by 1.2 percent to 2,067, the size of the investments rose increased from $18.91 billion in […]

France is considering a biotech tax cut believing that tax reform will boost innovation, but I’m not so sure that companies decide on starting or relocating to one country over another based on some tax cuts. The proposal is for special tax status for “young listed companies” (“jeunes entreprises cotees”) that would help companies after […]

According to a new survey, US universities increased the number of licenses and options executed by over 20% between fiscal years (FY) 2001 and 2003. However, the number of startups created from such licenses dropped 17%. The Association of University Technology Managers (AUTM), released its latest annual licensing survey, which covers FY2003. AUTM sent questionnaires […]

The Ohio Valley Affiliates for Life Sciences Group (OVALS) will host it’s regional conference  "The Promise of Innovation: OVALS Making It Happen" on March 7-8, 2005, at the Dayton Marriott Hotel in Dayton, Ohio.  TOPICS INCLUDE: Policy to financing: emerging trends in life sciences Creating building blocks for university/industry agreements Moving from lab to market: […]

Cincinnati Children’s Hospital Medical Center will begin making investments in biotech companies built around technologies originally developed at the medical center. Cincinnati Children’s Tomorrow Fund will provide early-stage angel and seed capital to new Cincinnati-based companies to develop to the point where traditional venture capital and other funding is attainable. The Tomorrow Fund received $500,000 […]

The Business First of Columbus news publication reported that Ohio was ranked No. 11 in biopharmaceutical venture capital funding in an October study by the Milken Institute.  The study noted Ohio’s Third Frontier Project, a 10-year plan to spur the state’s high-tech economy, for increasing money spent on biotech.  Massachusetts ranked No. 1 in the […]